Evonik Evonik

X

Find Ropidoxuridine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Ropidoxuridine
Also known as: 93265-81-7, Ipdr, 5-iodo-2-pyrimidinone-2'-deoxyribose, Ipd-r, 3hx21a3sqf, 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone
Molecular Formula
C9H11IN2O4
Molecular Weight
338.10  g/mol
InChI Key
XIJXHOVKJAXCGJ-XLPZGREQSA-N
FDA UNII
3HX21A3SQF

Ropidoxuridine is an orally available 5-substituted 2-pyrimidinone-2'-deoxyribonucleoside analogue and prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine, with radiosensitizing activity. Upon oral administration, ropidoxuridine (IPdR) is efficiently converted to idoxuridine (IUdR) by a hepatic aldehyde oxidase. In turn, IUdR is incorporated into DNA during replication, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. Compared to IUdR, ropidoxuridine is associated with a lower toxicity profile and improved anti-tumor activity.
1 2D Structure

Ropidoxuridine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one
2.1.2 InChI
InChI=1S/C9H11IN2O4/c10-5-2-11-9(15)12(3-5)8-1-6(14)7(4-13)16-8/h2-3,6-8,13-14H,1,4H2/t6-,7+,8+/m0/s1
2.1.3 InChI Key
XIJXHOVKJAXCGJ-XLPZGREQSA-N
2.1.4 Canonical SMILES
C1C(C(OC1N2C=C(C=NC2=O)I)CO)O
2.1.5 Isomeric SMILES
C1[C@@H]([C@H](O[C@H]1N2C=C(C=NC2=O)I)CO)O
2.2 Other Identifiers
2.2.1 UNII
3HX21A3SQF
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone

2. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside

3. 5-iodo-2-pyrimidinone-2'-deoxyribose

4. Ipdr

2.3.2 Depositor-Supplied Synonyms

1. 93265-81-7

2. Ipdr

3. 5-iodo-2-pyrimidinone-2'-deoxyribose

4. Ipd-r

5. 3hx21a3sqf

6. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone

7. Nsc-726188

8. 2(1h)-pyrimidinone, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-iodo-

9. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1h)-one

10. Ropidoxuridine [usan]

11. Unii-3hx21a3sqf

12. Ropidoxuridine (inn/usan)

13. Ropidoxuridine [usan:inn]

14. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside

15. Ropidoxuridine [inn]

16. Schembl8602575

17. Chembl2103821

18. Dtxsid00239353

19. Zinc6091380

20. 5-iodo-2-pyrimidinone-2-deoxyribose

21. Db06485

22. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one

23. Hy-13742

24. Cs-0007768

25. D08992

26. D96122

27. 265i817

28. A901121

29. Q27257237

30. 5-iodo-1-(2-deoxy-beta-d-ribofuranosyl)pyrimidin-2(1h)-one

31. 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodopyrimidin-2(1h)-one

32. 2(1h)-pyrimidinone, 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodo-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 338.10 g/mol
Molecular Formula C9H11IN2O4
XLogP3-0.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass337.97635 g/mol
Monoisotopic Mass337.97635 g/mol
Topological Polar Surface Area82.4 Ų
Heavy Atom Count16
Formal Charge0
Complexity357
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in cancer/tumors (unspecified).


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY